First Time Loading...

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.1155 CHF 0.43% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

ADXN Price Targets Summary
Addex Therapeutics Ltd

Wall Street analysts forecast ADXN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADXN is 0.1632 CHF with a low forecast of 0.1616 CHF and a high forecast of 0.168 CHF.

ADXN Lowest Forecast
Wall Street Target
0.1616 CHF
40% Upside
ADXN Average Forecast
Wall Street Target
0.1632 CHF
41% Upside
ADXN Highest Forecast
Wall Street Target
0.168 CHF
45% Upside
Lowest
Price Target
0.1616 CHF
40% Upside
Average
Price Target
0.1632 CHF
41% Upside
Highest
Price Target
0.168 CHF
45% Upside
Addex Therapeutics Ltd Competitors:
Price Targets
D
002030
Daan Gene Co Ltd
92% Upside
SNPX
Synaptogenix Inc
209% Upside
BIOG B
Biogaia AB
34% Upside
TNGX
Tango Therapeutics Inc
141% Upside
D
002030
Daan Gene Co Ltd
92% Upside
SNPX
Synaptogenix Inc
209% Upside
BIOG B
Biogaia AB
34% Upside
TNGX
Tango Therapeutics Inc
141% Upside
E
1952
Everest Medicines Ltd
3% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
33% Upside
Y
YS
YS Biopharma Co Ltd
451% Upside
MDXG
MiMedx Group Inc
103% Upside

Revenue
Forecast

Revenue Estimate
Addex Therapeutics Ltd

For the last 8 years the compound annual growth rate for Addex Therapeutics Ltd's revenue is 9%.

9%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Addex Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Addex Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
What are analyst estimates?

See Also

Summary
ADXN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADXN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADXN stock valuation using valuation multiples.
Wall Street Estimates
ADXN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADXN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADXN's stock price target?
Price Target
0.1632 CHF

According to Wall Street analysts, the average 1-year price target for ADXN is 0.1632 CHF with a low forecast of 0.1616 CHF and a high forecast of 0.168 CHF.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.